Finbar Larkin - May 9, 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: SVP, Technical Operations
Signature: By: /s/Adam Guttmann, as attorney in fact For: Finbar Larkin
Stock symbol: JAZZ
Transactions as of: May 9, 2022
Transactions value $: -$260,193
Form type: 4
Date filed: 5/11/2022, 05:35 PM
Previous filing: Mar 9, 2022
Next filing: Sep 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Sale	-$260K	-1.75K	-8.24%	$148.94	19.5K	May 9, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2	Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Content

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.